미국의 유방 보존 수술 시장 규모, 점유율, 동향 분석 리포트 : 시술별, 제품별, 최종 용도별, 부문별 예측(2025-2033년)

Market Size & Trends:

The U.S. breast conserving surgery market size was estimated at USD 744.32 million in 2024 and is projected to grow at a CAGR of 7.18% from 2025 to 2033. The market growth is attributed to the rising prevalence of early-stage breast cancer, supported by widespread mammography screening programs and patient awareness campaigns. These initiatives have led to an increase in early detection rates, making more patients eligible for breast-conserving procedures like lumpectomy and quadrantectomy. In addition, there is a strong preference for procedures that preserve breast appearance and function, especially among younger patients, which aligns with the principles of breast conserving surgery (BCS).

The growth of ambulatory surgical settings is a key driver of the U.S. market, offering a cost-effective, patient-friendly alternative to inpatient hospital procedures. These settings are increasingly equipped with advanced surgical technologies, experienced staff, and streamlined processes that make them well suited for procedures like BCS, which are typically less invasive and have shorter recovery times.

U.S. Breast Conserving Surgery Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. breast conserving surgery market report based on procedure, product, and end use:

• Procedure Outlook (Revenue, USD Million, 2021 - 2033)
• Lumpectomy
• Quadrantectomy
• Segmental Mastectomy
• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Tumor Localization Devices
  • Wire-guided localization
  • Magnetic seed localization
  • Radar-based localization
  • Others
• Surgical Excision Devices
  • Electrosurgical units/devices
  • Scalpels/forceps/retractors/clamps
  • Vacuum-assisted biopsy systems
  • Others
• Margin Assessment Devices
• Intraoperative Imaging & Navigation Devices
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Oncology/Specialty Clinics
• Others

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database.
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Third Party Perspective
  • 1.3.5. Primary research
  • 1.3.6. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights Outlook

Chapter 3. U.S. Breast Conserving Surgery Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Related/ancillary market outlook.
• 3.2. User Perspective Analysis
  • 3.2.1. Consumer behavior analysis
• 3.3. Market Dynamics
  • 3.3.1. Market driver analysis
    • 3.3.1.1. Increasing breast cancer incidence and focus on early detection
    • 3.3.1.2. Rising preference for cosmetic and functional preservation
    • 3.3.1.3. Technological advancement in wireless localization and AI-based margin assessment
    • 3.3.1.4. Growth of ambulatory surgical settings
    • 3.3.1.5. Favorable government and reimbursement support in developed nations
  • 3.3.2. Market restraint analysis
    • 3.3.2.1. High cost of advanced technologies
    • 3.3.2.2. Limited access to early diagnosis
  • 3.3.3. Market opportunity analysis
    • 3.3.3.1. Shift toward outpatient & minimally invasive procedures
  • 3.3.4. Market challenge analysis
    • 3.3.4.1. Reoperation risk due to positive margins
• 3.4. U.S. Breast Conserving Surgery Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic landscape

Chapter 4. U.S. Breast Conserving Surgery Market: Procedure Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Breast Conserving Surgery Market: Procedure Movement Analysis & Market Share, 2024 & 2033
• 4.3. Lumpectomy
  • 4.3.1. Lumpectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.4. Quadrantectomy
  • 4.4.1. Quadrantectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Segmental Mastectomy
  • 4.5.1. Segmental Mastectomy Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Breast Conserving Surgery Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Breast Conserving Surgery Market: Product Movement Analysis & Market Share, 2024 & 2033
• 5.3. Tumor Localization Devices
  • 5.3.1. Tumor Localization Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3.2. Wire-Guided Localization
    • 5.3.2.1. Wire-guided localization market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.3.3. Magnetic Seed Localization
    • 5.3.3.1. Magnetic seed localization market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.3.4. Radar-Based Localization
    • 5.3.4.1. Radar-based localization market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.3.5. Others
    • 5.3.5.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
• 5.4. Surgical Excision Devices
  • 5.4.1. Surgical Excision Devices Market Estimates And Forecasts 2021 to 2033 (USD Million)
  • 5.4.2. Electrosurgical Units/Devices
    • 5.4.2.1. Electrosurgical units/devices market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.3. Scalpels/Forceps/Retractors/Clamps
    • 5.4.3.1. Scalpels/forceps/retractors/clamps market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.4. Vacuum-Assisted Biopsy Systems
    • 5.4.4.1. Vacuum-assisted biopsy systems market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.4.5. Other
    • 5.4.5.1. Other market estimates and forecasts 2021 to 2033 (USD Million)
• 5.5. Margin Assessment Devices
  • 5.5.1. Margin Assessment Devices Market Estimates And Forecasts 2021 to 2033 (USD Million)
• 5.6. Intraoperative Imaging & Navigation Devices
  • 5.6.1. Intraoperative Imaging & Navigation Devices Market Estimates And Forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Breast Conserving Surgery Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Breast Conserving Surgery Market: End Use Movement Analysis & Market Share, 2024 & 2033
• 6.3. Hospitals
  • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.4. Ambulatory Surgery Centers
  • 6.4.1. Ambulatory Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Oncology/Specialty Clinics
  • 6.5.1. Oncology/Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Others
  • 6.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company/Competition Categorization
  • 7.2.1. Innovators
• 7.3. Vendor Landscape
  • 7.3.1. List of key distributors and channel partners
  • 7.3.2. Key customers
  • 7.3.3. Key company market share analysis, 2024
  • 7.3.4. Hologic, Inc
    • 7.3.4.1. Company overview
    • 7.3.4.2. Financial performance
    • 7.3.4.3. Product benchmarking
    • 7.3.4.4. Strategic initiatives
  • 7.3.5. Argon Medical Devices
    • 7.3.5.1. Company overview
    • 7.3.5.2. Financial performance
    • 7.3.5.3. Product benchmarking
    • 7.3.5.4. Strategic initiatives
  • 7.3.6. Merit Medical Systems
    • 7.3.6.1. Company overview
    • 7.3.6.2. Financial performance
    • 7.3.6.3. Product benchmarking
    • 7.3.6.4. Strategic initiatives
  • 7.3.7. KUBTEC
    • 7.3.7.1. Company overview
    • 7.3.7.2. Financial performance
    • 7.3.7.3. Product benchmarking
    • 7.3.7.4. Strategic initiatives
  • 7.3.8. Stryker
    • 7.3.8.1. Company overview
    • 7.3.8.2. Financial performance
    • 7.3.8.3. Product benchmarking
    • 7.3.8.4. Strategic initiatives
  • 7.3.9. Mammotome (Danaher)
    • 7.3.9.1. Company overview
    • 7.3.9.2. Financial performance
    • 7.3.9.3. Product benchmarking
    • 7.3.9.4. Strategic initiatives
  • 7.3.10. CairnSurgical Inc.
    • 7.3.10.1. Company overview
    • 7.3.10.2. Financial performance
    • 7.3.10.3. Product benchmarking
    • 7.3.10.4. Strategic initiatives
  • 7.3.11. Lumicell Inc
    • 7.3.11.1. Company overview
    • 7.3.11.2. Financial performance
    • 7.3.11.3. Product benchmarking
    • 7.3.11.4. Strategic initiatives
  • 7.3.12. Innoblative Designs
    • 7.3.12.1. Company overview
    • 7.3.12.2. Financial performance
    • 7.3.12.3. Product benchmarking
    • 7.3.12.4. Strategic initiatives
  • 7.3.13. Perimeter Medical Imaging AI
    • 7.3.13.1. Company overview
    • 7.3.13.2. Financial performance
    • 7.3.13.3. Product benchmarking
    • 7.3.13.4. Strategic initiatives